Aimt stock earnings

Aimmune Therapeutics Inc (NASDAQ:AIMT) – Stock analysts at Wedbush cut their Q1 2020 earnings per share estimates for Aimmune Therapeutics in a report released on Tuesday, March 3rd. Wedbush analyst L. Moussatos now forecasts that the biotechnology company will post earnings of ($0.84) per share for the quarter, down from their prior estimate of ($0.80). […] AIMT Stock Price, Forecast & News (Aimmune Therapeutics)

AIMT:NASDAQ GS Stock Quote - Aimmune Therapeutics Inc ... Stock analysis for Aimmune Therapeutics Inc (AIMT:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Aimmune Therapeutics Inc - TheStreet Aimmune Therapeutics To Host Conference Call And Webcast To Discuss Fourth Quarter And Full-Year 2019 Financial Results And Recent Operational Highlights Aimmune Therapeutics, Inc. Revenue & Earnings ... - NASDAQ.com Aimmune Therapeutics, Inc. (AIMT) Revenue, Earnings Per Share (EPS), & Dividend Get free financial information for Aimmune Therapeutics, Inc. including revenue, earnings per share (EPS), and company dividend at NASDAQ.com

Find the latest and the upcoming Aimmune Therapeutics earnings report Apr 5, 2020 as well as EPS Forecast and AIMT top analyst price The TipRanks Smart Score analyzes stocks based on 8 factors extracted from our unique datasets.

Aimmune Therap (AIMT) reports earnings on 5/28/2020. Shares are down 37.2% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. What's in Store for Aimmune (AIMT) This Earnings Season? Feb 19, 2020 · Immunomedics, Inc. IMMU has an Earnings ESP of +3.37% and a Zacks Rank of 2. You can see the complete list of today’s Zacks #1 Rank stocks here.. Free: Zacks’ Single Best Stock Set … Aimmune Therapeutics, Inc. - AIMT - Stock Price Today - Zacks

Aimmune Therapeutics Inc (AIMT) Q4 2019 Earnings Call ...

Apr 03, 2020 · Real-time trade and investing ideas on Aimmune Therapeutics AIMT from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Investor Overview | Aimmune Therapeutics Aimmune Therapeutics, Inc. is a biopharmaceutical company developing oral immunotherapy treatments for food allergies. AIMT: Aimmune Therapeutics, Inc. - Earnings News ... As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. AIMT | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for AIMMUNE THERAPEUTICS INC (AIMT), including profile, stock chart, recent news and events, analyst opinions, and research reports. Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.

AIMT - Aimmune Therap Stock Price - Barchart.com

Earnings for Aimmune Therapeutics Inc.

View the latest Aimmune Therapeutics Inc. (AIMT) stock price, news, historical charts, analyst ratings and financial Per-Share Earnings, Actuals and Estimates .

Earnings Whisper Number for AIMT: Aimmune Therap Aimmune Therap (AIMT) reports earnings on 5/28/2020. Shares are down 37.2% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings.

Aimmune Therapeutics Inc (AIMT) Q4 2019 Earnings Call ... AIMT earnings call for the period ending December 31, 2019. Aimmune Therapeutics Inc (AIMT) Q4 2019 Earnings Call Transcript | The Motley Fool Latest Stock Picks AIMT Aimmune Therapeutics — Stock Price and Discussion ...